| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |